• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肢端肥大症猫的垂体病理学与基因表达

Pituitary Pathology and Gene Expression in Acromegalic Cats.

作者信息

Scudder Christopher J, Mirczuk Samantha M, Richardson Karen M, Crossley Victoria J, Regan Jacob T C, Gostelow Ruth, Forcada Yaiza, Hazuchova Katarina, Harrington Norelene, McGonnell Imelda M, Church David B, Kenny Patrick J, Korbonits Márta, Fowkes Robert C, Niessen Stijn J M

机构信息

Diabetic Remission Clinic, Department of Clinical Science and Services, Royal Veterinary College, North Mymms, United Kingdom.

Endocrine Signaling Group, Department of Comparative Biomedical Sciences, Royal Veterinary College, London, United Kingdom.

出版信息

J Endocr Soc. 2018 Oct 16;3(1):181-200. doi: 10.1210/js.2018-00226. eCollection 2019 Jan 1.

DOI:10.1210/js.2018-00226
PMID:30620005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6316999/
Abstract

The prevalence of GH-secreting pituitary tumors in domestic cats () is 10-fold greater than in humans. The predominant inhibitory receptors of GH-secreting pituitary tumors are somatostatin receptors (SSTRs) and D dopamine receptor (DRD2). The expression of these receptors is associated with the response to somatostatin analog and dopamine agonist treatment in human patients with acromegaly. The aim of this study was to describe pathological features of pituitaries from domestic cats with acromegaly, pituitary receptor expression, and investigate correlates with clinical data, including pituitary volume, time since diagnosis of diabetes, insulin requirement, and serum IGF1 concentration. Loss of reticulin structure was identified in 15 of 21 pituitaries, of which 10 of 15 exhibited acinar hyperplasia. , , , and mRNA were identified in the feline pituitary whereas and were not. Expression of , , and was greater in acromegalic cats compared with controls. A negative correlation was identified between mRNA expression and pituitary volume. The loss of DRD2 expression should be investigated as a mechanism allowing the development of larger pituitary tumors.

摘要

家猫中分泌生长激素的垂体肿瘤患病率比人类高10倍。分泌生长激素的垂体肿瘤的主要抑制性受体是生长抑素受体(SSTRs)和D2多巴胺受体(DRD2)。这些受体的表达与肢端肥大症人类患者对生长抑素类似物和多巴胺激动剂治疗的反应相关。本研究的目的是描述患有肢端肥大症的家猫垂体的病理特征、垂体受体表达,并研究与临床数据的相关性,包括垂体体积、糖尿病诊断后的时间、胰岛素需求量和血清IGF1浓度。在21个垂体中的15个中发现网状纤维结构丧失,其中15个中的10个表现为腺泡增生。在猫垂体中鉴定出、、和mRNA,而未鉴定出和。与对照组相比,肢端肥大症猫中、和的表达更高。在mRNA表达与垂体体积之间发现负相关。DRD2表达的丧失应作为允许更大垂体肿瘤发展的一种机制进行研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c14/6316999/004dca3beced/js.2018-00226f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c14/6316999/16e9bc1e8f6d/js.2018-00226f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c14/6316999/32e453f95b0e/js.2018-00226f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c14/6316999/02d78cf66d8d/js.2018-00226f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c14/6316999/c07d10662454/js.2018-00226f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c14/6316999/93f46cc7cbb6/js.2018-00226f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c14/6316999/004dca3beced/js.2018-00226f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c14/6316999/16e9bc1e8f6d/js.2018-00226f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c14/6316999/32e453f95b0e/js.2018-00226f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c14/6316999/02d78cf66d8d/js.2018-00226f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c14/6316999/c07d10662454/js.2018-00226f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c14/6316999/93f46cc7cbb6/js.2018-00226f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c14/6316999/004dca3beced/js.2018-00226f6.jpg

相似文献

1
Pituitary Pathology and Gene Expression in Acromegalic Cats.肢端肥大症猫的垂体病理学与基因表达
J Endocr Soc. 2018 Oct 16;3(1):181-200. doi: 10.1210/js.2018-00226. eCollection 2019 Jan 1.
2
BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.BIM-23A760,一种靶向生长抑素和多巴胺受体的嵌合分子,与生长抑素受体通用配体在对奥曲肽部分应答的生长激素分泌型垂体腺瘤中的比较
J Endocrinol Invest. 2005;28(11 Suppl International):21-7.
3
Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas.Bim-23244,一种生长抑素受体2型和5型选择性类似物,在抑制来自对奥曲肽耐药的人生长激素分泌腺瘤的生长激素(GH)方面具有增强的疗效。
J Clin Endocrinol Metab. 2001 Jan;86(1):140-5. doi: 10.1210/jcem.86.1.7099.
4
Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs.垂体中的生长抑素受体与生长抑素受体亚型选择性类似物的研发
Endocrine. 2003 Apr;20(3):265-9. doi: 10.1385/ENDO:20:3:265.
5
Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes.肢端肥大症中的人类生长抑素受体亚型:信使核糖核酸表达和激素抑制的不同模式可识别不同的肿瘤表型。
J Clin Endocrinol Metab. 2000 Feb;85(2):781-92. doi: 10.1210/jcem.85.2.6338.
6
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy.针对多种生长抑素和多巴胺受体的嵌合分子对生长激素分泌型垂体腺瘤生长激素和催乳素分泌抑制作用的疗效,这些垂体腺瘤被归类为对生长抑素类似物治疗部分反应性。
Eur J Endocrinol. 2005 Jul;153(1):135-41. doi: 10.1530/eje.1.01950.
7
Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment.促甲状腺素分泌型垂体腺瘤中生长抑素受体亚型mRNA:一例显示短期奥曲肽治疗期间肿瘤大小显著缩小的病例
Endocr J. 2007 Jun;54(3):371-8. doi: 10.1507/endocrj.k06-177. Epub 2007 Apr 10.
8
Dopamine 2 and somatostatin 1-5 receptors coexpression in clinically non-functioning pituitary adenomas.多巴胺2受体与生长抑素1-5受体在临床无功能垂体腺瘤中的共表达
Physiol Res. 2015;64(3):369-77. doi: 10.33549/physiolres.932821. Epub 2014 Dec 22.
9
Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.新型生长抑素配体的临床前和临床经验:优势、劣势与新前景。
J Endocrinol Invest. 2005;28(11 Suppl International):36-42.
10
Dissociation between tumor shrinkage and hormonal response during somatostatin analog treatment in an acromegalic patient: preferential expression of somatostatin receptor subtype 3.一名肢端肥大症患者在生长抑素类似物治疗期间肿瘤缩小与激素反应的分离:生长抑素受体亚型3的优先表达
J Endocrinol Invest. 2006 Oct;29(9):826-30. doi: 10.1007/BF03347378.

引用本文的文献

1
Hypersomatotropism and Hypercortisolism Caused by a Plurihormonal Pituitary Adenoma in a Dog.犬垂体多激素腺瘤引起的生长激素过多症和皮质醇增多症
J Vet Intern Med. 2025 Jul-Aug;39(4):e70177. doi: 10.1111/jvim.70177.
2
Expression of somatostatin receptors in canine and feline meningioma.在犬和猫脑膜瘤中生长抑素受体的表达。
Vet Med Sci. 2024 Jul;10(4):e1537. doi: 10.1002/vms3.1537.
3
Hepatic Gene Expression of Angiogenic and Regeneration Markers in Cats with Congenital Portosystemic Shunts (CPSS).先天性门体分流(CPSS)猫肝脏中血管生成和再生标志物的基因表达

本文引用的文献

1
Somatostatin receptor ligands in the treatment of acromegaly.生长抑素受体配体在肢端肥大症治疗中的应用
Pituitary. 2017 Feb;20(1):100-108. doi: 10.1007/s11102-017-0791-0.
2
Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary.生长激素分泌型垂体腺瘤及垂体生长激素细胞增生的病理学
Pituitary. 2017 Feb;20(1):84-92. doi: 10.1007/s11102-016-0748-8.
3
Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway.多巴胺D2受体通过抑制表皮生长因子受体/蛋白激酶B/基质金属蛋白酶-13通路抑制胃癌细胞的侵袭和迁移。
Vet Sci. 2024 Feb 26;11(3):100. doi: 10.3390/vetsci11030100.
4
Feline Comorbidities: Hypersomatotropism-induced diabetes in cats.猫科动物共患病:由过度生长激素分泌引起的猫糖尿病。
J Feline Med Surg. 2024 Feb;26(2):1098612X241226690. doi: 10.1177/1098612X241226690.
5
Transsphenoidal hypophysectomy for the treatment of hypersomatotropism secondary to a pituitary somatotroph adenoma in a dog.经蝶窦垂体切除术治疗犬垂体生长激素腺瘤继发的过度生长激素血症。
J Vet Intern Med. 2024 Jan-Feb;38(1):351-357. doi: 10.1111/jvim.16929. Epub 2023 Nov 2.
6
Quality of life and response to treatment in cats with hypersomatotropism: the owners' point of view.患有肢端肥大症的猫的生活质量和治疗反应:主人的观点。
J Feline Med Surg. 2022 Aug;24(8):e175-e182. doi: 10.1177/1098612X221098718. Epub 2022 May 26.
7
Cabergoline treatment in cats with diabetes mellitus and hypersomatotropism.卡麦角林治疗患有糖尿病和生长激素过多症的猫。
J Feline Med Surg. 2022 Dec;24(12):1238-1244. doi: 10.1177/1098612X221074924. Epub 2022 Feb 8.
8
Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment.卡麦角林治疗后患有肾上腺皮质功能亢进的猫的糖尿病缓解。
JFMS Open Rep. 2021 Jul 13;7(2):20551169211029896. doi: 10.1177/20551169211029896. eCollection 2021 Jul-Dec.
9
Diabetes mellitus remission in three cats with hypersomatotropism after cabergoline treatment.卡麦角林治疗后三只肢端肥大症猫的糖尿病缓解
JFMS Open Rep. 2021 May 31;7(1):20551169211018991. doi: 10.1177/20551169211018991. eCollection 2021 Jan-Jun.
10
Efficacy of hypophysectomy for the treatment of hypersomatotropism-induced diabetes mellitus in 68 cats.垂体切除术治疗 68 例高生长激素血症性糖尿病的疗效。
J Vet Intern Med. 2021 Mar;35(2):823-833. doi: 10.1111/jvim.16080. Epub 2021 Feb 24.
Int Immunopharmacol. 2016 Oct;39:113-120. doi: 10.1016/j.intimp.2016.07.002. Epub 2016 Jul 25.
4
Incidence and prevalence of acromegaly in a large US health plan database.美国一个大型健康计划数据库中肢端肥大症的发病率和患病率。
Pituitary. 2016 Jun;19(3):262-7. doi: 10.1007/s11102-015-0701-2.
5
Endochondral Growth Defect and Deployment of Transient Chondrocyte Behaviors Underlie Osteoarthritis Onset in a Natural Murine Model.软骨下生长缺陷和一过性软骨细胞行为的展开是天然鼠模型中骨关节炎发病的基础。
Arthritis Rheumatol. 2016 Apr;68(4):880-91. doi: 10.1002/art.39508.
6
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study.预测第一代生长抑素类似物抵抗的生长激素垂体腺瘤对培高利特反应的因素:免疫组织化学研究。
Eur J Endocrinol. 2016 Feb;174(2):241-50. doi: 10.1530/EJE-15-0832. Epub 2015 Nov 19.
7
Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors.生长激素垂体瘤组织学亚型中生长抑素受体(SSTR)1 - 5的差异表达及下游效应器
Mol Cell Endocrinol. 2015 Dec 5;417:73-83. doi: 10.1016/j.mce.2015.09.016. Epub 2015 Sep 21.
8
Studying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter.研究猫(家猫)糖尿病:谨防肢端肥大症冒名者。
PLoS One. 2015 May 29;10(5):e0127794. doi: 10.1371/journal.pone.0127794. eCollection 2015.
9
Pasireotide for the Medical Management of Feline Hypersomatotropism.帕西瑞肽用于猫肢端肥大症的药物治疗
J Vet Intern Med. 2015 Jul-Aug;29(4):1074-80. doi: 10.1111/jvim.12608. Epub 2015 May 6.
10
Acromegaly: an endocrine society clinical practice guideline.肢端肥大症:内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2014 Nov;99(11):3933-51. doi: 10.1210/jc.2014-2700. Epub 2014 Oct 30.